On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more
FDA approves new treatment for advanced soft tissue sarcoma
Most Recent Content
For Nurse Practitioners
AHA: It’s Safe to Treat High Blood Pressure During Pregnancy
High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...
